J&J's Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules 'Not An Innovative Drug'
![Janssen's Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU - Thailand Medical News Janssen's Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU - Thailand Medical News](https://www.thailandmedical.news/uploads/editor/files/Janssen%E2%80%99s%20Esketamine%20Nasal%20Spray(1).jpg)
Janssen's Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU - Thailand Medical News
![Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada - Psychedelic Alpha Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada - Psychedelic Alpha](https://psychedelicalpha.com/wp-content/uploads/2021/01/Weekly-Psychedelic-Bulletin-300x128.jpg)
Psychedelic Bulletin: UK Patent Examiner Questions Compass Patent; Canadians Overwhelmingly Support Psilocybin Policy Reform; No Data Protection for Spravato in Canada - Psychedelic Alpha
![Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior](https://mma.prnewswire.com/media/1222835/SPRAVATO_Logo.jpg?p=facebook)
Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
![Federal Court Of Canada Dismisses Janssen's Application To Reassess The Data Protection Eligibility Of Its Nasal Spray Product Federal Court Of Canada Dismisses Janssen's Application To Reassess The Data Protection Eligibility Of Its Nasal Spray Product](https://www.dww.com/sites/default/files/styles/landscape_ri/public/shutterstock_271586141.jpg?itok=oB-ydZcI)